Skip Nav Destination
CONTINUING MEDICAL EDUCATION (CME) QUESTIONS|
April 16, 2020
REMARC survival discrimination by TMTV post-RCHOP
CME
Blood (2020) 135 (16): 1411.
Article history
First Edition:
March 10, 2020
Connected Content
A related article has been published:
High total metabolic tumor volume at baseline predicts survival independent of response to therapy
This is a related article to:
Predicting the future for DLBCL
Citation
REMARC survival discrimination by TMTV post-RCHOP. Blood 2020; 135 (16): 1411. doi: https://doi.org/10.1182/blood.2020005771
Download citation file:
April 16 2020
Advertisement intended for health care professionals
Cited By
Advertisement intended for health care professionals
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal